Meta tags:
Headings (most frequently used words):
this, website, is, no, longer, valid, этот, сайт, больше, не, действителен,
Text of the page (most frequently used words):
our (15), #english (14), #icon (10), page (10), #medicines (7), #next (7), the (7), #links (7), #quick (7), #research (7), spanish (6), about (6), #information (6), and (5), medical (5), business (5), development (4), resources (4), investors (4), access (4), bms (4), french (4), request (4), careers (4), global (4), united (4), #this (3), releases (3), areas (3), patient (3), annual (3), history (3), drug (3), media (3), german (3), contact (3), website (3), for (3), stories (3), press (3), valid (3), healthcare (3), providers (3), patients (3), researchers (3), longer (3), caregivers (3), leadership (3), position (3), news (3), portuguese (2), medinfo (2), learn (2), dutch (2), 800 (2), 250 (2), markets (2), arabic (2), russia (2), other (2), com (2), publications (2), contacts (2), diversity (2), your (2), related (2), report (2), inclusion (2), bristol (2), commitment (2), product (2), team (2), pre (2), previous (2), notice (2), stock (2), или (2), clinical (2), site (2), search (2), main (2), looking (2), chinese (2), states (2), statement (2), locations (2), worldwide (2), company (2), squibb (2), myers (2), corporate (2), trials (2), post (2), approval (2), study (2), system (2), interest (2), czech (2), shareholders (2), focus, perspectives, psoriasis, thomas, head, from, sponsored, disclosure, portal, around, sheet, investigator, grants, fact, get, practice, 340b, daniel, collaboration, incubator, efforts, voices, generic, expert, drugs, immunology, stem, pricing, rems, independent, risk, world, evaluation, mitigation, center, help, pipeline, strategies, 2024, paying, thailand, korean, zealand, new, singapore, taiwan, traditional, thai, japanese, europe, austria, belgium, republic, denmark, danish, korea, japan, finnish, chile, skip, close, americas, argentina, brazil, canada, colombia, india, mexico, peru, pacific, asia, australia, china, simplified, finland, france, bmsuscqpagelucene, hebrew, switzerland, requests, kingdom, east, middle, israel, arabia, sweden, saudi, turkey, turkish, emirates, arab, distributor, swedish, spain, germany, italian, greece, greek, hungary, hungarian, ireland, italy, luxembourg, romanian, netherlands, norway, norwegian, poland, polish, portugal, romania, competitive, begin, technology, необходимостью, препаратах, информацию, медицинскую, либо, какую, получить, продукции, пожалуйста, качеству, претензией, явлении, нежелательном, сообщением, бмс, отправьте, связано, complaint, quality, event, adverse, действителен, больше, электронное, сайт, этот, телефону, позвоните, адресу, письмо, обращение, obtain, human, legal, privacy, trademarks, forward, pdf, trafficking, slavery, navigation, follow, 2022, july, home, you, ваше, homepage, если, here, click, below, bar, use, see, were, exist, doesn, removed, been, has, need, any, compound, results, split, calculator, return, investment, filings, sec, quarterly, 2023, summary, sales, archive, reports, meeting, partnerships, dividend, investor, partner, financial, process, sharing, data, medicine, translational, reporting, coverage, acquisition, analyst, presentations, events, services, shareholder, celgene, with, why, products, resource, today, survivorship, technologies, timeline, foundation, groups, people, sustainability, issues, key, call, email, send, please, week, responsibility, discussion, contests, alliances, innovation, early, brochure, download, ticket, disease, golden, meetings, library, scientific, infographics, state, content,
Text of the page (random words):
this website is no longer valid our medicines our stories investors skip to main content contact us careers united states close icon americas argentina spanish brazil portuguese canada english french chile spanish colombia spanish mexico spanish peru spanish united states english asia pacific australia english china simplified chinese india english japan japanese korea korean new zealand english singapore english taiwan traditional chinese thailand english thai europe austria german belgium english dutch french czech republic czech denmark danish finland finnish france french germany german greece greek hungary hungarian ireland english italy italian luxembourg english netherlands english dutch norway norwegian poland polish portugal portuguese romania romanian spain spanish sweden swedish switzerland german french united kingdom english middle east israel hebrew saudi arabia english arabic turkey turkish united arab emirates english arabic other other markets distributor markets bmsuscqpagelucene medicines careers press releases medical information previous page icon previous page icon our medicines patients caregivers next page icon patients caregivers our medicines get help paying for your medicines patient resources risk evaluation and mitigation strategies rems quick links immunology patient resources our position on generic drugs our position on drug pricing psoriasis around the world healthcare providers next page icon healthcare providers learn about pre approval access learn about post study drug access 340b practice fact sheet quick links u s medical information clinical trials pre approval access request system post study drug access request system researchers next page icon researchers areas of focus in the pipeline r d expert voices our efforts in stem clinical trials research independent research the thomas o daniel research incubator and collaboration center quick links perspectives from our head of research research publications disclosure commitment investigator sponsored research portal areas of interest competitive research grants compound technology requests data sharing request process translational medicine investors next page icon investors stock information financial reporting analyst coverage events and presentations shareholder services acquisition related information for celgene shareholders investor contacts quick links annual report 2023 dividend history stock split history investment return calculator sec filings quarterly results product sales summary annual reports archive annual meeting of shareholders business development next page icon business development our partnerships why partner with us areas of interest business development leadership team begin a discussion global alliances leadership team early innovation at bms quick links download business development brochure golden ticket contests news next page icon news press releases our stories medical meetings media library media contacts quick links scientific media resources disease state infographics corporate publications about us next page icon about us our company leadership global inclusion diversity responsibility sustainability contact us quick links global patient week survivorship today our technologies history timeline worldwide locations the bristol myers squibb foundation people business resource groups our commitment to global inclusion and diversity position on key issues this website is no longer valid this website is no longer valid if your request is related to a report of an adverse event a product quality complaint or a need to obtain any medical information about bms products please send an email to medinfo russia bms com or call 7 800 250 12 12 этот сайт больше не действителен если ваше обращение связано с сообщением о нежелательном явлении претензией к качеству продукции или необходимостью получить какую либо медицинскую информацию о препаратах бмс пожалуйста отправьте электронное письмо по адресу medinfo russia bms com или позвоните по телефону 7 800 250 12 12 the site page you were looking for has been removed or doesn t exist click here to see the corporate site homepage or use the search bar below search medicines careers press releases medical information main navigation home patients caregivers healthcare providers researchers investors news about us resources our medicines legal notice privacy notice trademarks forward looking statement uk ca slavery and human trafficking statement pdf follow us careers our stories contact us worldwide locations july 01 2022 2024 bristol myers squibb company
|